Hepatotoxicity SIG: Drug Induced Liver Injury: Assessing Risk and Predicting Outcome
Recorded On: 11/08/2019
Clinicians and translational researchers will glean approaches to assess drug induced liver injury (DILI) risk and predict outcomes at this session. Faculty will review basic hepatic drug metabolism in healthy and diseased livers, strategies to detect DILI during drug treatment and possible DILI risk factors, such as dose, duration, genetics and immunity. They will also share useful databases for clinicians.
Jay H. Hoofnagle